PATENT CLAIM ANALYSIS

Application Number: 16134831
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "093100"]

Abstract:
The present invention provides a method for lowering blood glucose levels in an animal by transplanting a population of pancreatic endocrine precursor cells into an animal.

Claim (Index 3):
The method of  claim 2 , wherein the TGF-\u03b2 receptor I kinase inhibitor is Alk 5 inhibitor II.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 97.0
- Lexical Diversity: 1.125
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12838998', '12970330', '12839041', '13998883', '13998884']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7475544803681817
- 35 USC 102 Novelty (BERT): 0.7493788909232032
- Combined Prediction Score: 0.747736921423684
- Mean Citation Score: 649.751884
- Max Citation Score: 844.9823
- Similarity Product: 836.1226157476781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test